If AI continues to trample the creators of new code and frameworks, then where will our new code and frameworks come from?
IntraBio Inc. today announced that the European Commission granted marketing authorization to AQNEURSA® (levacetylleucine) for the treatment of neurological manifestations of Niemann-Pick Type C (NPC) ...
Gone are the days when designing a website meant that you needed to understand a coding language such as HTML or Javascript.